Correction of pyrimidine derivatives of immunologic activity of the organism and external respiration function for prevention of the lingering course of acute pneumonia
- Authors: Slabnov Y.D.1, Valimukhametova D.A.1, Tsibulkin A.P.1, Khamitov R.F.1
-
Affiliations:
- Kazan Institute for Advanced Training of Physicians named after V.I.Lenin
- Issue: Vol 74, No 3 (1993)
- Pages: 193-197
- Section: Articles
- Submitted: 05.04.2021
- Accepted: 05.04.2021
- Published: 15.06.1993
- URL: https://kazanmedjournal.ru/kazanmedj/article/view/64685
- DOI: https://doi.org/10.17816/kazmj64685
- ID: 64685
Cite item
Open Access
Access granted
Abstract
The effect of xymedon on immunologic indices and external respiration function in combined treatment of patients with acute pnemonia is studied. The use of xymedon in the presence of basis therapy in patients with lingering pneumonia with reduced immunologic reactivity exerts a stimulating effect on the indices of cellular and humoral immunity. This effect is revealed in the stabilization period of pneumonia accompanied by positive clinicoroentgenologic shifts, provides a higher increase of the indices of external respiration function, reduces the terms of recovery of patients. Xymedon does not cause side effects. The drug may be recommended for a wider use in the clinic in patients with unspecific diseases of the lungs.
Keywords
Full Text
About the authors
Yu. D. Slabnov
Kazan Institute for Advanced Training of Physicians named after V.I.Lenin
Author for correspondence.
Email: info@eco-vector.com
Russian Federation
D. A. Valimukhametova
Kazan Institute for Advanced Training of Physicians named after V.I.Lenin
Email: info@eco-vector.com
Russian Federation
A. P. Tsibulkin
Kazan Institute for Advanced Training of Physicians named after V.I.Lenin
Email: info@eco-vector.com
Russian Federation
R. F. Khamitov
Kazan Institute for Advanced Training of Physicians named after V.I.Lenin
Email: info@eco-vector.com
Russian Federation
References
- Беленький Е. Е., Рупихин Ю. А., Туницкая Т. А. Фармакологическая регуляция регенеративных процессов.—Йошкар-Ола, 1979.
- Горбунов С. М. Фармакотоксикологическая характеристика ксимедона и влияние его на заживление термических ожогов кожи: Автореф. дисс. канд. мед. наук.— Казань, 1979.
- Ермаков Е. В., Медников Б. Л., Чернов А. П. и др. Yep. арх.—1982.—№ 9.—С. 47— 50.
- Завражнов В. И. Материалы конференции по применению пиримидиновых производных в онкологии и других областях медицины,—Л., 1963.
- Зильбер Е. А., Шунько Б. Е. Тер. арх.—1981.—№ 3.—С. 87—91.
- Кочнев О. С., Измайлов С. Г. Казанский мед. ж,—1990.—№ 5,—С. 373—375.
- Сильевестров В. П., Караулов А. В., Тер. арх.—1984.—№ З.-С. 3—11.
- Сильвестров В. П., Федотов П. И. Пневмония.—М., 1987.
- Слабнов Ю. Д. Экспериментальное обоснование применения ксимедона как иммуномодулятора: Автореф. дисс. канд. мед. наук.—Казань, 1988.
- Хамитов X. С., Валимухаметова Д. А., Цибулькин А. П. и др. Ксимедон—Казань, 1986.
- Joticlal М., Holm J., Wigzel Н. А. exp. Med.—1972,—Vol. 136.—P. 207—215.
- Mancini I., Corbonaro A. 0., Heretnuns Q. S. Immunnochemistry.—1965.—Vol. 2,— P. 23—25.
Supplementary files
